Cleared Traditional

CSM BETA-LACTAMASE DISC (K822518) - FDA 510(k) Clearance

K822518 · Carr-Scarborough Microbiologicals, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1982
Decision
29d
Days
-
Risk

K822518 is an FDA 510(k) clearance for the CSM BETA-LACTAMASE DISC.

Submitted by Carr-Scarborough Microbiologicals, Inc. (Mchenry, US). The FDA issued a Cleared decision on September 21, 1982 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Carr-Scarborough Microbiologicals, Inc. devices

Submission Details

510(k) Number K822518 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 23, 1982
Decision Date September 21, 1982
Days to Decision 29 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
73d faster than avg
Panel avg: 102d · This submission: 29d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code -
Device Class -